Abstract:Our previous studies have shown that the novel selective RNA polymerase I inhibitor CX-5461 suppresses proliferation of vascular smooth muscle cells, mainly by inducing DNA damage response (DDR), including activations of ataxia telangiectasia mutated (ATM)/ATM and Rad3-related (ATR) and p53. Currently, there is no information about the molecular mechanism(s) underlying CX-5461-induced DDR in vascular cells, while the results obtained in cancer cells and immortalized cell lines are controversial. In this study, we examined the responses of various DDR pathways to CX-5461 treatment in primary aortic smooth muscle cells isolated from normal adult Sprague Dawley rats. We demonstrated that CX-5461-induced DDR was not associated with activations of the nucleotide excision repair, DNA mismatch repair, or the non-homologous end joining pathways, while the homologous recombination pathway was activated. However, the alkaline comet assay did not show massive DNA double strand breaks in CX-5461-treated cells. Instead, CX-5461-induced DDR appeared to be related to induction of DNA replication stress, which was not attributable to increased formation of G-quadruplex or R-loop structures, but might be explained by the increased replication-transcription conflict. CX-5461-induced DDR was not exclusively confined to rDNA within the nucleolar compartment; the extra-nucleolar DDR might represent a distinct secondary response related to the downregulated Rad51 expression in CX-5461-treated cells. In summary, we suggest that DNA replication stress may be the primary molecular event leading to downstream ATM/ATR and p53 activations in CX-5461-treated vascular smooth muscle cells. Our results provide further insights into the molecular basis of the beneficial effects of CX-5461 in proliferative vascular diseases.

Multiple Repair Pathways Mediate Cellular Tolerance to Resveratrol-Induced DNA Damage.

The mechanism of resveratrol induced DNA damages in DT40 cells

Resveratrol Sequentially Induces Replication and Oxidative Stresses to Drive P53-Cxcr2 Mediated Cellular Senescence in Cancer Cells

Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway

DSB-induced oxidative stress: Uncovering crosstalk between DNA damage response and cellular metabolism

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance

Regulatory effects of resveratrol on antioxidant enzymes: A mechanism of growth inhibition and apoptosis induction in cancer cells

Modulation of ionizing radiation-induced damage in human blood lymphocytes by in vivo treatment with resveratrol

Molecular basis of CX-5461-induced DNA damage response in primary vascular smooth muscle cells

Exploiting the Role of Resveratrol in Rat Mitochondrial Permeability Transition

RAD52 Adjusts Repair of Single-Strand Breaks via Reducing DNA-Damage-Promoted XRCC1/LIG3α Co-localization

Relationship between Targeting Rad51 and Cancer Treatment

Molecular Events Leading to Cx-5461-Induced DNA Damage Response in Vascular Smooth Muscle Cells

Recent advances in DNA damage repair mechanism

DNA Damage Induced by Resveratrol and Its Synthetic Analogues in the Presence of Cu (II) Ions: Mechanism and Structure-Activity Relationship.

The Determinant of DNA Repair Pathway Choices in Ionising Radiation-Induced DNA Double-Strand Breaks

Critical Roles of Rad54 in Tolerance to Apigenin-Induced Top1-mediated DNA Damage.

The Role of Single Strand Break Repair Pathways in Cellular Responses to Camptothecin Induced DNA Damage

Resveratrol triggers autophagy‐related apoptosis to inhibit the progression of colorectal cancer via inhibition of FOXQ1

Transient HR enhancement by RAD51-stimulatory compound confers protection on intestinal rather than hematopoietic tissue against irradiation in mice

DNA Repair Phenotype and Cancer Susceptibility—a Mini Review